worldwide and has a significant economic impact on the horse breeding industry. Current treatments for R. equi infections involve combination drug therapies with rifampin and macrolides such as clarithromycin (Giguè re et al., 2011) . These treatments can be protracted and expensive, and are not always successful. Furthermore, antibiotic resistant strains are emerging (Andersen et al., 1997; Asoh et al., 2003) . While vaccine trials are on-going and making headway (Hooper-McGrevy et al., 2005; Dawson et al., 2010; Whitehead et al., 2012) , there are still no commercially available vaccines, and research investigations are now focussing on the mechanism of pathogenicity induced by R. equi in order to provide insights which may ultimately lead to better treatments for infection.
R. equi is a Gram-positive coccobacillus with a lipid-rich cell envelope characteristic of the mycolata, a group of acid-fast actinomycetes that includes Mycobacterium, Corynebacterium and Nocardia species. It metabolises a wide range of organic and inorganic compounds and thrives on the mixture of organic compounds found in animal manure. Virulent R. equi enter alveolar macrophages by receptor-mediated phagocytosis and survive and proliferate in phagosomes. The bacterium has the ability to halt phagosome maturation prior to the late endocytic stage, thereby protecting it from normal bacteriocidal factors and allowing it to proliferate (Fernandez-Mora et al., 2005) . Virulence of R. equi strains is strictly associated with the possession of an $80 kbp plasmid (Takai et al., 1991b ; Tkachuk-Saad and Prescott, Fig. 1 . The virulence genes/proteins of R. equi. (A) The 21.3 kb pathogenicity island region of the equine type R. equi plasmid pVAPA1037. The genes encoding the homologous virulence associated proteins Vaps A, C, D, E, G, H are shown in blue with a one letter label. The pseudogenes vapF, vapI and vapX are shown in turquoise. The genes encoding the transcriptional regulators virR (a LysR type transcriptional regulator) and virS (an orphan two-component system response regulator) are coloured in orange. Expression of vapA appears to be controlled indirectly by VirR in response to temperatures above 30 8C and acidic pH by production of VirS (green arrow) (Russell et al., 2004) , which is required for transcription of the vapAIC(orfAB)D operon (purple arrow) (Kakuda et al., 2014) ; the small uncharacterised ORFs (orfAB) that lie between vapC and vapD are not shown for clarity. The promoter associated with the vcgABC operon (uncharacterised vap co-expressed genes) shares homology with the vapA promoter (Miranda-CasoLuengo et al., 2011) suggesting that a similar mode of regulation may operate. Observed transcripts are related as orange arrows (Byrne et al., 2007 (Byrne et al., , 2008 ; Kakuda et al., 2014; Miranda-CasoLuengo et al., 2011) . (B) Comparison of the amino acid sequences of the Vap proteins of the R. equi horse virulence plasmid together with VapB form the porcine virulence plasmid. The sequences were aligned in CLUSTALW (Thompson et al., 1994) and displayed together with the secondary structure elements of VapG using the programme ESPRIPT (Robert and Gouet, 2014) . Invariant residues in the alignment are shown in white type on a red background; conserved residues are in blue boxes (For interpretation of the colour information in this figure legend, the reader is referred to the web version of the article.). 1991). Plasmid-cured strains do not proliferate in macrophages, are cleared in murine models of infection, and are avirulent in foals (Hondalus and Mosser, 1994; Wada et al., 1997; Giguè re et al., 1999) . The virulence plasmid harbours a pathogenicity island (Fig. 1A) containing 26 coding sequences including that for the virulence-associated protein A (VapA). VapA is an $20 kDa immunodominant protein present in clinical isolates of infected foals (Takai et al., 1991a,b; Tan et al., 1995) . A strain of R. equi with a vapA deletion mutation was shown to be unable to grow in macrophages and to be incapable of establishing infection in mice pointing to an essential role in virulence (Jain et al., 2003) . However, plasmid-encoded factors other than VapA are needed for virulence since expression of wild type levels of VapA in otherwise virulent, plasmid-cured strains of R. equi does not restore virulence in mice or foals (Giguè re et al., 1999) . Similarly, in plasmid pathogenicity island-deleted strains of R. equi, constitutive expression of vapA could delay clearance of the pathogen from mice but it did not restore virulence (Coulson et al., 2010) . Thus vapA is necessary but not sufficient for virulence and other pathogenicity island-encoded factors are required.
Also encoded on the pathogenicity island are a set of virulence-associated proteins highly homologous to VapA; VapC, VapD, VapE, VapG, and VapH (Fig. 1A) . In addition, there are three pseudogenes vapF, vapI and vapX which are not thought to code for functional proteins since they harbour substantial truncations and/or frameshifts. The role of these additional vap genes and whether they encode proteins with overlapping or redundant functions is not established. The available evidence indicates that these genes are not essential for virulence, at least in mice, since a mutant deleted for vapA, -C, -D, -E is complemented by vapA expressed in trans (Jain et al., 2003) . The vap genes are induced by elevated temperature, starvation of various metals, and low pH, conditions likely to be encountered in the macrophage (Benoit et al., 2001; Ren and Prescott, 2003) . vapA expression is dependent on two pathogenicity island factors, virR, which encodes a LysR type transcriptional regulator and virS (orf8) which encodes an orphan two-component system response regulator (Fig. 1A) (Ren and Prescott, 2003; Russell et al., 2004) . Each of the vap genes encodes a secretion signal peptide consistent with the translocation of their gene products to the outside of the cell where many have been detected by immunoblotting of R. equi culture supernatants (Byrne et al., 2001) . By contrast, VapA appears to be retained on the bacterial cell surface (Takai et al., 1992) .
In order to provide a framework for a new set of studies to investigate the critical function(s) of VapA and its role in R. equi virulence, we and others have sought to determine its three-dimensional structure. However, crystals of VapA have proved elusive and efforts were directed towards homologous Vap proteins. The crystal structures of two Vap proteins, VapB whose gene resides on a plasmid present in R. equi isolates from pigs (Geerds et al., 2014) and VapD (Whittingham et al., 2014) have been determined. An alignment of the sequences of the six plasmidencoded Vap proteins from horse isolates of R. equi together with VapB from pig isolates is presented in Fig. 1B . The structures revealed that the highly conserved C-terminal residues form an eight-stranded b-barrel. In the case of VapD, circular dichroism as well as crystallographic data indicated that the N-terminal region of the protein, whose sequence is poorly conserved across the Vap family, is intrinsically disordered. Here, we are concerned with a third virulence-associated protein VapG. vapG expression is known to be highly up-regulated in R. equi infected macrophages and in the lungs of infected foals. However, deletion mutagenesis showed VapG to be dispensible for growth of the pathogen in macrophages and in vivo in mice (Coulson et al., 2010) . In this work, we present the crystal structure of VapG and compare its structure to those of VapB and VapD. The results are discussed in terms of possible functions of the Vap proteins.
Materials and methods

Protein production and purification
VapG was cloned as a commercial service by Eurofins Operon in pET23b. Native R. equi sequence was used and fused directly with restriction sites for NdeI (5 0 , with the ATG of the restriction site representing the start codon) and EcoRI (3 0 , directly after the last codon) to form pET23-matvapG.
Transformants of Escherichia coli BL21 (DE3) carrying pET23-vapG were grown overnight in 10 ml LB broth supplemented with 100 mg ml À1 ampicillin at 37 8C with shaking at 200 rpm. This overnight preculture was used to inoculate 1 l of Terrific broth (100 mg ml À1 ampicillin) and grown at 37 8C to an OD 600 of 0.5-0.7 at 180 rpm, 37 8C. The culture was cooled to 16 8C and recombinant gene expression was induced by the addition of 1 mM IPTG; cultures were held at 16 8C overnight before harvesting by centrifugation at 2880 Â g for 10 min at 4 8C. Pelleted cells were re-suspended to 10 ml/g in 0.02 M Tris-HCl (pH 7.4, containing 0.5 M NaCl, 0.03 M imidazole) and lysed by exposing resuspended cells (in 5 ml aliquots) to 6 cycles of 10 s sonication/10 s cooling with amplitude setting at 10 m using a MSE Soniprep 150 ultrasonic disintegrator. The lysate was clarified by centrifugation at 27,000 Â g for 30 min at 4 8C.
Recombinant protein was purified from the clarified lysate via a two-step process using Immobilised Metal Affinity Chromatography (IMAC) on Ni 2+ -charged Chelating Sepharose Fast Flow resin (GE healthcare Life Sciences) followed by anion-exchange chromatography on HiTrap Q HP. Firstly, the IMAC column (10 ml bed volume) was equilibrated with 200 ml of 0.02 M Tris-HCl (pH 7.4) containing 0.03 M imidazole, 0.5 M NaCl (otherwise known as equilibration buffer) at a flow rate of 5 ml/min (for 20 min). The clarified lysate was loaded onto the column at a flow rate of 2 ml/min and washed with the equilibration buffer at a flow rate of 4 ml/min for 25 min. Elution of bound protein was effected via an linear gradient if imidazole concentration (from 0.03 to 0.5 M) at a flow rate of 4 ml/min. Eluate was collected in 4 ml fractions. The composition of each fraction was analysed on SDS-PAGE to identify those containing VapG.
Fractions containing VapG were pooled and concentrated to about 0.5 ml by centrifuging at 2880 Â g, 4 8C using a 10 kDa Vivaspin 20 Centrifugal Concentrator (Sartorius Stedim Biotech, France). This process was repeated three times with 20 ml of ice-cold 0.02 M TrisHCl (pH 8.0) to remove imidazole and NaCl. After the final concentration, the sample was diluted to a final volume of 20 ml in the same buffer and subjected to anion exchange chromatography on a 5 ml bed volume HiTrap Q HP column equilibrated with 0.02 M Tris-HCl (pH 8.0) at a flow rate of 5 ml/min. The VapG-enriched sample was applied at a flow rate of 2 ml/min and eluted with 0.02 M Tris-HCl, 1 M NaCl (pH 8.0) at a flow rate of 4 ml/min in a linear gradient using 0.02 M Tris-HCl (pH 8.0) as the diluent.
Size-exclusion chromatography with multi-angle laser light scattering (SEC-MALLS)
For the determination of the oligomeric state of VapG, the protein was analysed by SEC-MALLS. Samples of protein at concentrations of 4 mg/ml were loaded onto a Superdex S75 10/300 gel-filtration column equilibrated at 0.5 ml min À1 with a mobile phase consisting of 50 mM Tris-HCl pH 8.0, 150 mM NaCl. The eluate was passed through an SPD20A UV-vis detector, a Wyatt Dawn HELEOS-II 18-angle light-scattering detector and a Wyatt Optilab rEX refractive index monitor with the system driven by a Shimadzu HPLC system comprising an LC-20AD pump. The data were processed and molecular masses were calculated using the Astra V software (Wyatt) as described previously (Colledge et al., 2011) .
Protein crystallisation, data collection, structure solution and refinement
Crystals were obtained using a protein solution consisting of VapG at 30 mg ml À1 in 10 mM Tris-HCl (pH 7.5), 10 mM NaCl. The crystals grew at 18 8C by hanging drop vapour diffusion against a reservoir solution containing 0.3 M potassium chloride, 20% PEG 3350, originating from the Peg/Ion screen (Hampton Research). A crystal of approximate dimensions 400 mm Â 400 mm Â 400 mm was vitrified in cryoprotectant solution (30% glycerol, 70% reservoir) and X-ray diffraction data were collected at 100 K at the Diamond Light Source experimental station I02. Data were integrated using XDS (Kabsch, 2010) and scaled/merged with Aimless (Evans, 2011) . The structure of VapG was solved by molecular replacement with the program MOLREP (Vagin and Teplykov, 2010 ) using a family-related structure VapD (PDB code 4csb, Whittingham et al., 2014 ) as a search model, this sharing 60% amino acid sequence identity with VapG (Fig. 1B) . Two solutions were found equating to two molecules of VapG per asymmetric unit. The resulting model was refined using maximum likelihood methods implemented in REFMAC5 (Murshudov et al., 2011) with 5% of the total data excluded from the refinement for the purpose of R free calculations. This procedure was interspersed with manual corrections to the model using COOT (Emsley et al., 2010) in conjunction with 2F o À F c and F o À F c electron density maps.
During refinement, elongated peaks of positive difference electron density appeared in two independent locations in the asymmetric unit. These peaks had the appearance of additional protein chains or peptides bound between the protein molecules: in one location a sequence of three histidines was built and successfully refined; in the other the sequence ALAA was built. It was concluded that these elements formed parts of the C-terminal affinity tags from the two VapG molecules, with the ALAA corresponding to the tag sequence KLAA in one molecule and AALE in its symmetry mate. Another striking feature in the electron density maps was a strong metal ion peak located at the centre of a cluster of main chain and side chains oxygen donors from residues 107 to 114 of molecule A. The coordination distances ranged from 2.7 to 3.1 Å which was consistent with a potassium ion (Harding, 2002) . Although other metal ion candidates (calcium and magnesium) were tested out in refinement, potassium was the only one which refined satisfactorily. Furthermore, X-ray absorption analysis of a single crystal revealed no other metal ions present apart from potassium, which was a crystallisation component. Refinement statistics and structural information are listed in Table 1 .
Structure analysis
During analysis of the structure, multiple sequence alignment was performed using CLUSTAL-W (Thompson et al., 1994) and displayed using ESPript 3.0 (Robert and Gouet, 2014) . Three dimensional structural alignments were made using secondary-structure matching (Krissinel and Henrick, 2004) implemented in COOT (Emsley et al., 2010) . All figures were generated using CCP4mg (McNicholas et al., 2011) . 
where I i is the intensity of the ith measurement of a reflection with indexes hkl and hIi is the statistically weighted average reflection intensity.
c R cryst = P jjF o j À jF c jj/ P jF o j, where F o and F c are the observed and calculated structure factor amplitudes, respectively.
d R-free is the R cryst calculated with 5% of the reflections chosen at random and omitted from refinement. e Average geometric restraints given in parentheses.
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Results
Characterisation of recombinant VapG
The purified recombinant VapG protein was analysed by size exclusion chromatography with multi-angle laser light scattering. Here the protein is fractionated on a gel filtration column and the absorbance at 280 nm and the refractive index of the eluate are monitored together with the multi-angle light scattering of the sample. This enables the weight average molecular weight (M w ) of the eluting protein to be calculated continuously. The data from this experiment are shown in Fig. 2 . Applying this analysis, we determined a molecular mass of 15.2 kDa for mature VapG fused to a C-terminal LEHHHHHH sequence. This compares with the mass calculated from the amino acid sequence of 16.0 kDa. It is clear therefore that VapG is a monomer.
Crystal structure of VapG
The recombinant protein used to obtain crystals comprised the mature VapG polypeptide (Fig. 1B) fused to a 20-residue sequence (PNSSSVDKLAAALEHHHHHH) at the C-terminus of the protein which included a polyhistidine affinity tag. As described earlier, the extended fusion portion of the protein formed intermolecular contacts critical for crystal growth. The asymmetric unit of the crystal contained two independent VapG molecules (molecules A and B). The refined structure consists of residues 42-147 of chain A and 41-147 of chain B. The low complexity N-terminal regions (residues up to and including Asn 41 of chain A, and Ala 40 of chain B) were not visible in the electron density maps. These residues were assumed, therefore, to be disordered. The same is true for most of the C-terminal tags (residues Asn 148 -His 166 )
though short segments at the centre of these sequences were visible, mediating lattice contacts. The A and the B molecules are virtually identical in fold. Following superposition of the two chains by least squares methods, the root mean squared deviation (rmsD) in corresponding C a atom positions is 0.45 Å . Each molecule consists of eight b-strands and a single a-helix. The strands assemble to form a compact, anti-parallel b-barrel, which is elliptical in cross section (Fig. 3) , and which has a b1-b2-b3-b8-b5-b6-b7-b4 topology. The N-and Ctermini are each at the lower end of the barrel when it is viewed as in Fig. 3A and B. Thus b-turns link strands which are adjacent in the barrel; b1 and b2, and b5 and b6, at the top of the molecule and b2 and b3, and b6 and b7, at the base of the molecule. The remaining inter-strand connections, b3-b4 and b7-b8 at the top of the molecule (Fig. 3C ) and b4-b5 at the base (Fig. 3D) cross-over the barrel effectively acting as caps that close off its ends. The b4-b5 connector contains the nine-residue a-helix. The short turns between strands and their close packing give the upper end of the molecule a smooth rounded surface, compared to the base where the b2-b3 and b6-b7 turns protrude outwards from the molecule to accommodate the a-helix.
The VapG protein fold described here was observed earlier for VapB and VapD and can be described as consisting of two Greek-key motifs separated by a small a-helix (Geerds et al., 2014; Whittingham et al., 2014) .
Despite the numerous occurrences of eight stranded b-barrel structures in the protein data bank (www.ebi. ac.uk/pdbe), the b1-b2-b3-b8-b5-b6-b7-b4 topology has not been observed elsewhere and it appears, therefore, that the Vap proteins are the defining members of a novel fold family.
Another interesting surface feature of the protein is a potassium ion which is bound at the head of the loop between b-strands 5 and 6 in molecule A (Fig. 4) (Fig. 4) . The equivalent site in molecule B does not contain a potassium ion as this site is occluded by the side chain of Ile 76 of molecule A, which forms a crystal contact. This tight packing arrangement appears to be the cause of minor chain distortions in this loop in molecule B compared to molecule A.
The protein core
The core of VapG consists of densely packed, hydrophobic side chains many of which are contributed by alternate residues of the b-strands (Fig. 5A) Curiously, the opposing half of the core is dominated by aliphatic side chains and devoid of aromatic groups (Fig. 5A) . Evidently, this arrangement facilitates close packing in the protein interior and presumably enhances the stability of the barrel. . Over the peak region, the molecular weight (MW) of the species (green line) in the eluate is calculated from the light scattering measurements (For interpretation of the colour information in this figure legend, the reader is referred to the web version of the article.). It is apparent that the barrel is closed off by the b3-b4 and b7-b8 segments when viewed from above (C) and by the a1 helix when viewed from below (D). In (C) the potassium ion has been omitted for clarity (For interpretation of the colour information in this figure legend, the reader is referred to the web version of the article.). unlikely to be present in VapC or VapH (Fig. 1B) . There is a second buried water which is hydrogen bonded to the side chain of Ser 51 (Fig. 5A ) and the main chain of residues Val 49 and Thr 134 .
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The protein surface
The distribution of ionisable, polar and apolar groups on the surface of VapG is noticeably uneven (Fig. 5B and C) . The upper third of the molecule viewed as in Fig. 5 (Fig. 5B) . Instead, the surface is dominated by exposed apolar side chains which give rise to an expansive hydrophobic surface area (Figs. 5B and 6C) which is extended by several conserved glycine residues which give this surface a flat as well as a neutral character. The lower reaches of the molecule on the other hand are significantly more polar. Seven of the 14 ionisable groups are located on or surrounding the a-helix at the base of the molecule while the remainder is located on a belt around the centre of the barrel (Fig. 5C ). The virulence-associated proteins are rich in glycine residues and the b-barrel domain of VapG contains 20 glycines in its 103 residues (Fig. 1B ). This compares with the frequency of 7.4% for the occurrence of glycine residues in proteins as a whole. The distribution of these glycine residues is shown in Fig. 5D . The absence of a side chain in glycine is associated with main chain conformational flexibility and a proportion of these residues most notably Gly respectively, combine to create a flat and rather featureless protein surface. At many of the glycine positions, the side chain R groups of a non-glycine residue would be inwardfacing and the presence of a Cb atom would be expected to disrupt the close packing in the protein core. Thus for example, the glycines at positions 137, 139, 141 and 143 allow strand b8 to pack closely over the 'aromatic ladder' with the polypeptide segment 136-144 making no contribution to the protein core. 
Structure comparisons with VapB and VapD
The structures of VapB, VapD and the two molecules of VapG are compared in Table 2 and Fig. 6 (Geerds et al., 2014; Whittingham et al., 2014) . The A and B molecules of VapG in the crystallographic asymmetric unit, coloured in different shades of blue, superpose more closely than either does onto VapB or VapD. Nevertheless, VapB, VapD and VapG share the same fold and are closely superimposable. It is apparent that VapB is more similar to VapD and VapG (lower pairwise rmsD values) than the latter pair is to each other, presumably reflecting the extent of sequence identity (Table 2 ). The molecules superimpose most closely in their central waist when viewed as in Fig. 6A , where the segments of structure form b-strands, and in the lower third of the structure where the only significant difference in structure is the b2-b3 loop where VapD and VapG contain one and five more residues than VapB, respectively. Otherwise, such differences as exist between pairs of structures are located in the loops at the opposite end of the molecule and these are apparent in Fig. 6B . One source of difference among the structures is the aspartic acid residue at the beginning of strand b4 in VapD (Whittingham et al., 2014) . This residue plays an important role in determining the conformation of the b7-b8 loop in this protein by forming charge-dipole interactions with main chain amides from four consecutive residues in this loop. These interactions distort the conformation of the b7-b8 loop away from that which obtains in VapB and VapG. In VapB and VapG, the aspartate is replaced by smaller apolar residues, Gly and Ala, respectively, which allow the closer approach of the As shown in Fig. 6C , all three Vap proteins exhibit an asymmetric distribution of ionisable/polar residues and there is an amphipathic character to the molecules along the axis of the barrel. The base of all three molecules is richer in areas of both positive and negative electrostatic potential while there is an extended apolar surface over the dome at the top of the molecule (Geerds et al., 2014; Whittingham et al., 2014) .
Discussion
The virulence plasmid of R. equi has long been recognised for its association with disease caused by this bacterium and VapA has emerged as a primary plasmidencoded virulence determinant. VapA is the defining member of a family of proteins related by sequence and which are encoded in multiple copies by three types of virulence plasmid in R. equi, pVAPA which is primarily associated with disease in horses, pVAPB which is primarily associated with disease in pigs and pVAPN which is primarily associated with bovine isolates (Vá zquez-Boland et al., 2013) . vap-family genes have also been discovered in other bacterial genomes where they occur in single copy. Here, they encode proteins that lack recognisable secretion signal peptides and their functions are unknown (Vá zquez-Boland et al., 2013; Whittingham et al., 2014) . As an immuno-dominant marker in infection and as an essential virulence factor in R. equi disease in horses, VapA has been a focus of research in this field. Despite these efforts, relatively little is known about the cellular role of VapA, its biochemical activity, and its functional relationship, if any, to the five plasmid-encoded orthologues.
The structure of VapG determined in this work, complements those of VapB and VapD determined previously (Geerds et al., 2014; Whittingham et al., 2014) . The close similarity of the three structures is no surprise given the high sequence identity and we can predict with confidence that the eight-stranded b-barrel (Leppiniemi et al., 2013; Leysen et al., 2011) . In both instances, the proteins have an anti-parallel allnext-neighbour b-barrel topology b1-b2-b3-b4-b5-b6-b7-b8. The absence of crossover strands lends these barrels intrinsically more open structures, allowing one end of the barrel to develop as a binding/active site with the barrel interior forming the base of a ligand-binding cavity. There is less potential for a binding site in the Vap proteins due to the altered topology which leads to segments (b3-b4 and b7-b8) crossing over, and closing off, the top of the barrel (Fig. 3) . At the opposing end, the barrel is closed off by the a-helix.
Similarly, the barrel domains of VapB, VapD and VapG have no obvious depressions or ridges on the protein surface to suggest protein interaction sites. This does not exclude the possibility that the Vaps are involved in interactions with other proteins since protein-protein recognition surfaces are variable in character (Janin et al., 2008) . Moreover, such interactions may be mediated by the natively unfolded amino terminal regions and accompanied by a disorder-to-order transition upon interaction with a cognate bacterial or host factor. Alternatively, it is possible that VapA and the other Vap proteins have functions, which are manifested following a conformational change in the protein. Conformational changes frequently accompany the binding of small molecules to proteins. For example, in the starvation sensor CodY of B. subtilis, the branched chain amino acid binding site is absent in the crystal structure of the unliganded protein, its formation in the presence of ligand is accompanied by a large spontaneous rearrangement of loops elaborated from a b-sheet (Levdikov et al., 2009) . Virulence factors in other pathogens undergo pH-dependent conformational changes. Indeed conformational changes in proteins associated with the phagolysosome pathway are amongst the largest to have been characterised by biophysical methods and observed/inferred from crystal structures (Bullough et al., 1994; Santelli et al., 2004) . One example is the protective antigen (PA) of Bacillus anthracis, the cell entry component of the two-component toxins secreted by the anthrax causing bacterium. Following receptor binding on the host cell surface, PA assembles to form a heptameric prepore that binds the partner toxin, lethal factor or oedema factor, before being taken into the cell by endocytosis. The lowering of the pH upon endosome maturation, leads to protonation of a cluster of histidine residues on PA (Santelli et al., 2004 ) and rearrangement of a 75 residue largely disordered segment of the polypeptide to form an extended pair of b-strands linked by a b-turn. In the heptamer, the result is a 14-stranded b-barrel which forms a pore in the endosome membrane allowing the lethal and oedema factors to gain access to the host cell cytoplasm where they exert their toxic effects. In influenza virus, the surface protein haemagglutinin (HA), which is involved in cell surface binding and viral endocytosis, undergoes a dramatic conformational change upon acidification of the endosome (Bullough et al., 1994) . Here, a cluster of aspartates becomes protonated as the pH is lowered allowing a random coil segment of HA to refold as an a-helix projecting the three amino terminal fusion peptides in the HA trimer 100 Å towards the endosome T. Okoko et al. / Veterinary Microbiology xxx (2015) xxx-xxxmembrane where they facilitate fusion of the viral and endosome membranes and release of the viral contents into host cell cytoplasm.
The Vap proteins of R. equi do not have a role in endocytosis, instead they are secreted into the endosome by the phagocytosed bacterium and they have simpler structures than PA or HA. pH-induced activation of the Vap proteins, and VapA in particular, is appealing conceptually and vap gene expression is known to be induced in R. equi grown in equine macrophages and this induction can be mimicked by growth of bacteria at 37 8C at pH 5 under conditions of metal limitation (Ren and Prescott, 2003) . However, a study of the maturation of R. equi-containing vesicles in mouse macrophages suggested many of the markers of the late endocytic stage were not acquired and there was arrest after completion of the early endosome stage (Fernandez-Mora et al., 2005) . Specifically, the proton pumping ATPase was not acquired and the vesicles were not acidified. The prevailing view is that VapA has an upstream role in preventing acidification of the R. equicontaining vacuole and therefore is unlikely to be pH-activated.
A second question that may be posed concerns the determinants of the VapA sequence/structure responsible for its dominant role among the Vap proteins as a virulence factor in foals. Despite their similarities, the Vaps can be distinguished immunologically and it was reported that antibodies that recognise VapA do not cross react with recombinant Vaps C, D or E (Byrne et al., 2001 ). The sequence variability at the N-terminus of the Vap proteins has obvious potential for conferring differential function. Equally, it is established that proteins that have a common structural framework can perform diverse functions, thus, the limited sequence and structural differences in the b-barrel domains may allow the Vap proteins to make selective interactions. In relation to virulence, VapA may make interactions with a host factor that leads to a block in endosome maturation.
VapA is reported to be retained on the bacterial cell surface, and this localisation may be selective since VapC, VapD and VapE were shown to be secreted into the culture supernatants (Byrne et al., 2001) . The cell surface presentation of VapA, perhaps as a complex with other bacterial factors or surface glycolipids, may be important in the virulence mechanism. It is also possible that the selective virulence properties of VapA are related to differential transcriptional regulation allowing the protein to attain a threshold concentration at a critical point in the life cycle of R. equi inside infected macrophages (Byrne et al., 2008) .
Conclusion
The Vap proteins of R. equi consist of b-barrel domains with disordered regions at their N-termini. There are no intrinsic or comparative features of the Vap protein structures that provide clues to function. The structures provide a framework for structure-function studies of VapA but fuller understanding of R. equi virulence depends on the future identification of the interacting molecular partners of the Vap proteins.
